US govt panel wants FDA to consider cybersecurity in pre- and post-market device reviews
This article was originally published in Clinica
Executive Summary
A US government advisory committee has recommended that the Food and Drug Administration take "cybersecurity" into account, both before and after approving software-controlled medical devices.